NCT02294357 2023-11-01Weekly 70 mg/m2 Carfilzomib for Multiple Myeloma Patients Refractory to 27 mg/m2 CarfilzomibOncotherapeuticsPhase 2 Terminated45 enrolled
NCT01177371 2010-08-09High-Dose Busulfan and High-Dose Cyclophosphamide Followed By Donor Bone Marrow Transplant in Treating Patients With Leukemia, Myelodysplastic Syndrome, Multiple Myeloma, or Recurrent Hodgkin or Non-Hodgkin LymphomaCase Comprehensive Cancer CenterPhase 2 Completed13 enrolled